Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects

A Phase-I, Two-Stage, Double-Blind, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Trial of Low Doses of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects.

The purpose of this study is to evaluate the safety and efficacy of intravenous 6β-Naltrexol administered to opiate dependent subjects

Inclusion Criteria:

• Opiate dependent males and females age 21-45 on stable doses of methadone
• Fluent English speaker
• Willing and able to give written consent

Exclusion Criteria:

• Pregnancy or lactation

FOR MORE DETAILS CONTACT THE RESEARCH CLINIC.